2019 Modern Radiotherapy for Hematologic Malignancies
This practical two-day meeting will provide updates on current clinical and translational initiatives in hematologic malignancies relevant to daily clinical practice.
This meeting is designed to meet the interests of medical oncologists, radiation oncologists, physicists, nurses, diagnostic radiologists, pathologists, radiation therapists, radiation dosimetrists and pediatric hematology-oncologists.
- Discuss the current guideline-based clinical practice in hematologic malignancies, in a case-based format.
- Use case examples to apply current hematologic malignancies guidelines into clinical practice.
- Discuss PET/CT response adaptive radiotherapy protocols for Hodgkin lymphoma and non-Hodgkin lymphoma.
- Apply involved-site radiotherapy (ISRT) for all disease sites – including Hodgkin lymphoma, and non-Hodgkin lymphoma.
- Apply multidisciplinary care in hematologic malignancies for optimal outcomes and discuss the importance of multidisciplinary care with others.
- Describe key advances in immunotherapy and targeted therapy in hematologic malignancies, and discuss special considerations when incorporating radiotherapy, keeping in mind potential overlapping toxicities.
- Integrate recent advances in new technology (i.e., IMRT, VMAT, deep inspiration breath hold, proton therapy) and explain to others how and when to integrate them.
- Describe key advances in imaging and its role in adaptive therapy protocols.
- Distinguish how late effects of radiotherapy, balanced against emerging data on dose-dependent late effects of chemotherapy, affects decision-making.
- Manage toxicities related to the management of hematologic malignancies.
- Summarize key recent advances in the understanding of the biology of hematologic malignancies.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
ASTRO designates this live activity for a maximum of 13.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CME certificates of credit are only available to participants who have completed the online evaluation tool. Participants who complete the evaluation within 30 days will have online access to their certificate 45 days post-meeting. Participants can access, print and save their certificate from the My ASTRO page of the ASTRO website. Participants who do not complete their evaluations within 30 days must contact ASTRO's Education Department to receive their certificate.
- 13.75 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Live activity for a maximum of 13.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 13.75 Certificate of AttendanceThis activity was designated for 13.75 AMA PRA Category 1 Credit™.